- Work address
-
Secretariaat Voorzitter Inwendige Ziekten C. Heymanslaan 10
9000 Gent - Cedric.Bosteels@UGent.be
- ORCID iD
-
0000-0003-3230-0879
Show
Sort by
-
- Journal Article
- A1
- open access
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
-
- Miscellaneous
- open access
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
-
- Journal Article
- A1
- open access
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
-
- Journal Article
- A1
- open access
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial
-
Isolation of conventional murine lung dendritic cell subsets
-
- Journal Article
- A1
- open access
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
-
- Journal Article
- A1
- open access
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
- Journal Article
- A1
- open access
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
-
- Journal Article
- A1
- open access
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19